Work

Pcn310 Real World Survival Outcomes With Modified Dose Schedule of Bortezomib, Melphalan and Prednisone in Previously Untreated Transplant Ineligible Patients With Multiple Myeloma: a Population Based Observational Study

Year: 2019

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2019.04.428

Authors: F. Schain, N. Batyrbekova, S. Cote

Institution: Janssen Canada (Canada)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2954322525

Cites:

Cited by:

Related to: 10